Weiqun Peng

17PUBLICATIONS
33CO-AUTHORS
Epigenetics (incl. genome methylation and epigenomics)Cancer therapy (excl. chemotherapy and radiation therapy)Cellular immunologyGenome structure and regulationTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Sep 22, 2026
PRMT1-SFPQ regulates intron retention to control matrix gene expression during craniofacial development.

|Jul 06, 2026
Exhausted CD8+ T cell fate is programmed by dynamic CTCF-mediated enhancer activation and invariant CTCF-imposed barriers.

|Jul 06, 2026
Mapping self-associating chromatin hubs identifies Id proteins as key determinants of exhausted CD8+ T cell fate.

|May 25, 2026
ISWI remodeler facilitates cBAF genomic binding to drive cell fate transition.

|Feb 09, 2026
Chromatin modifiers KMT2D, BAF, and p300 are required for de novo binding of transcription factors on enhancers.

Hieu T Van, Young-Kwon Park, Chengyu Liu

|Nov 26, 2025
PRMT1-SFPQ regulates intron retention to control matrix gene expression during craniofacial development.

Julia Raulino Lima, Nicha Ungvijanpunya, Qing Chen

Pageof 3

Frequent Collaborators

12 joint publications

Hai-Hui Xue

6 joint publications

Shengen Shawn Hu

6 joint publications

Chongzhi Zang

5 joint publications

Qing Chen